Scientists have used an AI model to reassess the results of a completed clinical trial for an Alzheimer's disease drug.

A new study sheds light on how behavioral symptoms are related to daily functioning in people with Alzheimer’s disease.

However, some research suggests that poor sleep could raise your risk of Alzheimer’s. A study published in November found ...

California is on the cusp of a demographic shift, with the number of people 65 and older skyrocketing by 59% over the next 15 ...

Leqembi is the first FDA-approved drug shown to slow the progression of early-stage Alzheimer’s. Medi-Cal can cover Leqembi ...

Alzheimer's disease (AD) is a progressive neurocognitive disease that slowly erodes an individual's memory, judgment, cognition, learning, and, eventually, ability to function. It is the leading ...

Massive proteomics database links gene variant APOE 4 to chronic inflammation.

Neurogen Biomarking will present novel data on at-home p-tau 217 testing for Alzheimer’s disease at the upcoming Alzheimer’s Association International Conference® (AAIC) in Toronto, Canada. Chief ...

Breast cancer treatment might offer protection against Alzheimer's disease, with a study of 70,000 survivors showing lower ...

Familial Alzheimer’s disease, which is very rare, is caused by gene mutations that run in your family and usually develops before age 65. Sporadic Alzheimer’s disease is more common.

The report offers the first estimates of Alzheimer’s disease prevalence in the US at the county level. Researchers used data from thousands of individuals who participated in the Chicago Health ...